2010
DOI: 10.1016/j.jasms.2009.12.004
|View full text |Cite
|
Sign up to set email alerts
|

Detection of nucleic acid-nuclear hormone receptor complexes with mass spectrometry

Abstract: Nuclear receptors, such as the retinoic acid receptor (RAR) or the 9-cis retinoic acid receptor (RXR), interact not only with their ligands but also with other types of receptors and with DNA. Here, two complementary mass spectrometry (MS) methods were used to study the interactions between retinoic receptors (RXR/RAR) and DNA: non-denaturing nano-electrospray (nanoESI MS), and high-mass matrix-assisted laser desorption ionization (MALDI MS) combined with chemical cross-linking. The RAR·RXR heterodimer was stu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2010
2010
2015
2015

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 55 publications
0
14
0
Order By: Relevance
“…Both non-denaturing nanoelectrospray ionization (nano-ESI) and high-mass matrix-assisted laser desorption ionization (MALDI) mass spectrometric methods were used to demonstrate that the RXR–RAR heterodimer bound to a DR-5 RARE in the presence of 9-cis-RA and that RXR was upstream (5′), in contrast to the DR-1 RARE in which RAR was upstream [6]. Crosslinking was used to stablilize the complex for MALDI, but did not necessarily stabilize the bound ligand.…”
Section: Introductionmentioning
confidence: 99%
“…Both non-denaturing nanoelectrospray ionization (nano-ESI) and high-mass matrix-assisted laser desorption ionization (MALDI) mass spectrometric methods were used to demonstrate that the RXR–RAR heterodimer bound to a DR-5 RARE in the presence of 9-cis-RA and that RXR was upstream (5′), in contrast to the DR-1 RARE in which RAR was upstream [6]. Crosslinking was used to stablilize the complex for MALDI, but did not necessarily stabilize the bound ligand.…”
Section: Introductionmentioning
confidence: 99%
“…In particular, mass spectrometry-based techniques are under development to determine higher-order structure and conformational dynamics of bioproducts [58,59]. This methodological approach has been largely proved as powerful and highly resolutive for the monitoring and screening of protein aggregation and formation of protein complexes in different biological contexts [60][61][62] and it has been even applied to determine the formation of protein oligomers in the basic research of fine protein-protein [63] and protein-nucleic acid [64] interactions. Intriguingly, mass spectrometry is used to analyze inhibitors of protein aggregation in the development of antiAlzheimer's disease drugs [65].…”
Section: Biological Production Of Protein Drugsmentioning
confidence: 99%
“…[14][15][16] High accuracy mass information is key, for example, for determining the stoi-chiometry of protein-protein, 3,4,17,18 protein-DNA, 19 or protein-RNA complexes. 20 Exact mass information is also used for the determination of the degree and the kind of post-translational modifications (PTMs), 7 PEGylations, 21 as well as for determining truncation of the primary sequence.…”
Section: Introductionmentioning
confidence: 99%